313 related articles for article (PubMed ID: 22843992)
1. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
[TBL] [Abstract][Full Text] [Related]
2. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer.
Wang CI; Wang CL; Wu YC; Feng HP; Liu PJ; Chang YS; Yu JS; Yu CJ
J Proteome Res; 2015 Apr; 14(4):1739-51. PubMed ID: 25728791
[TBL] [Abstract][Full Text] [Related]
4. mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells.
Wang CI; Chen YY; Wang CL; Yu JS; Chang YS; Yu CJ
Oncotarget; 2016 May; 7(18):25432-42. PubMed ID: 27009856
[TBL] [Abstract][Full Text] [Related]
5. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
Wang CI; Wang CL; Wang CW; Chen CD; Wu CC; Liang Y; Tsai YH; Chang YS; Yu JS; Yu CJ
Int J Cancer; 2011 May; 128(10):2364-72. PubMed ID: 20658535
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression.
Li XL; Jia LL; Shi MM; Li X; Li ZH; Li HF; Wang EH; Jia XS
J Transl Med; 2013 Sep; 11():232. PubMed ID: 24070213
[TBL] [Abstract][Full Text] [Related]
7. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.
Liao WC; Lin TJ; Liu YC; Wei YS; Chen GY; Feng HP; Chang YF; Chang HT; Wang CL; Chi HC; Wang CI; Lin KH; Ou Yang WT; Yu CJ
Cancer Sci; 2022 Jan; 113(1):205-220. PubMed ID: 34773335
[TBL] [Abstract][Full Text] [Related]
8. Acetylation regulates the nucleocytoplasmic distribution and oncogenic function of karyopherin alpha 2 in lung adenocarcinoma.
Feng HP; Liu YC; Wang CL; Liao WC; Yu JS; Yu CJ
Biochem Biophys Res Commun; 2023 Jun; 659():96-104. PubMed ID: 37060831
[TBL] [Abstract][Full Text] [Related]
9. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
[TBL] [Abstract][Full Text] [Related]
10. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract][Full Text] [Related]
11. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
Ma S; Zhao X
Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
[TBL] [Abstract][Full Text] [Related]
12. KPNA2 interacts with P65 to modulate catabolic events in osteoarthritis.
Tao R; Xu X; Sun C; Wang Y; Wang S; Liu Z; Zhai L; Cheng H; Xiao M; Zhang D
Exp Mol Pathol; 2015 Oct; 99(2):245-52. PubMed ID: 26209501
[TBL] [Abstract][Full Text] [Related]
13. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer.
Xiang S; Wang Z; Ye Y; Zhang F; Li H; Yang Y; Miao H; Liang H; Zhang Y; Jiang L; Hu Y; Zheng L; Liu X; Liu Y
Oncogene; 2019 Feb; 38(8):1269-1281. PubMed ID: 30254209
[TBL] [Abstract][Full Text] [Related]
14. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
15. Karyopherin alpha2 is essential for rRNA transcription and protein synthesis in proliferative keratinocytes.
Umegaki-Arao N; Tamai K; Nimura K; Serada S; Naka T; Nakano H; Katayama I
PLoS One; 2013; 8(10):e76416. PubMed ID: 24098495
[TBL] [Abstract][Full Text] [Related]
16. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
Duan M; Hu F; Li D; Wu S; Peng N
Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1.
Umegaki N; Tamai K; Nakano H; Moritsugu R; Yamazaki T; Hanada K; Katayama I; Kaneda Y
J Invest Dermatol; 2007 Jun; 127(6):1456-64. PubMed ID: 17255955
[TBL] [Abstract][Full Text] [Related]
18. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach.
Pan ST; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():937-68. PubMed ID: 25733813
[TBL] [Abstract][Full Text] [Related]
19. Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy.
He J; Yang L; Chang P; Yang S; Lin S; Tang Q; Wang X; Zhang YJ
Autophagy; 2020 Dec; 16(12):2238-2251. PubMed ID: 32924767
[TBL] [Abstract][Full Text] [Related]
20. Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinoma.
Yang Y; Guo J; Hao Y; Wang F; Li F; Shuang S; Wang J
Oncotarget; 2017 May; 8(22):36289-36304. PubMed ID: 28422734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
